Filter by

of 1 Next >
Results Found: 2
  • Action to Control Cardiovascular Risk in Diabetes Trial

    Alternate Title(s)
    ACCORD
    Description

    Action to Control Cardiovascular Risk in Diabetes (ACCORD) was a large clinical trial examining methods of lowering the rate of cardiovascular disease in adults with type two diabetes. The study was composed of three main clinical trials: an intensive lowering of blood sugar levels (Glycemia Trial), intensive lowering of blood pressure (Blood Pressure Trial), and treatment of multiple blood lipids...

    Subject
    Chronic Disease
    Access Rights
    Application Required
    Local Expert
    Lois Katz
  • NYU Dataset

    DIAPH1 Mediates Progression of Atherosclerosis and Regulates Hepatic Lipid Metabolism in Mice

    Authors
    Laura Senatus
    Lander Egana-Gorrono
    Raquel Lopez-Diez
    Sonia Bergaya
    17 more author(s)...
    Description

    Previous study indicated that the receptor for advanced glycation end products (RAGE) in the progression and regression of atherosclerosis. Therefore, this study examined if Diaphanous 1 (DIAPH1) binds to the RAGE cytoplasmic domain and contributes to progression of atherosclerosis. They intercrossed atherosclerosis prone Ldlr−/− mice with mice devoid of Diaph1 and fed them Western diet for 16 weeks....

    Subject
    Genomics
    Access Rights
    Free to All